Evaluation of a student clinical research education program in addiction medicine.
Ann Med.
2023 Dec;55(1):361-370. doi: 10.1080/07853890.2022.2154833. PubMed PMID:
36629696; PubMed Central PMCID:
PMC9848279.
Meeting the Moment: More Infectious Disease Physicians Must Be Prepared to Provide Buprenorphine.
Clin Infect Dis.
2023 Apr 3;76(7):1205-1208. doi: 10.1093/cid/ciad036. PubMed PMID:
36695340.
Barriers to accessing treatment for substance use after inpatient managed withdrawal (Detox): A qualitative study.
J Subst Abuse Treat.
2022 Nov;142:108870. doi: 10.1016/j.jsat.2022.108870. Epub 2022 Sep 1. PubMed PMID:
36084559; PubMed Central PMCID:
PMC10084712.
Filling in the Gaps: Building the Evidence Base for Screening, Brief Intervention, and Referral to Treatment in Adolescents.
J Adolesc Health.
2022 Oct;71(4S):S1-S4. doi: 10.1016/j.jadohealth.2022.06.023. PubMed PMID:
36122964; PubMed Central PMCID:
PMC10245381.
Medicaid Hepatitis C Virus Treatment Policies: Impact on Testing and Treatment in the Commercially Insured.
Am J Prev Med.
2022 Sep;63(3):e87-e98. doi: 10.1016/j.amepre.2022.03.010. Epub 2022 Jun 18. PubMed PMID:
35725599; PubMed Central PMCID:
PMC9676070.
How Do Medicaid Agencies Improve Substance Use Treatment Benefits? Lessons from Three States' 1115 Waiver Experiences.
J Health Polit Policy Law.
2022 Aug 1;47(4):497-518. doi: 10.1215/03616878-9716740. PubMed PMID:
35044466; PubMed Central PMCID:
PMC10688542.
Opioid agonist treatment and risk of death or rehospitalization following injection drug use-associated bacterial and fungal infections: A cohort study in New South Wales, Australia.
PLoS Med.
2022 Jul;19(7):e1004049. doi: 10.1371/journal.pmed.1004049. eCollection 2022 Jul. PubMed PMID:
35853024; PubMed Central PMCID:
PMC9295981.
Evaluation of an experiential clinical learning option during pandemic teaching suspensions.
BMC Med Educ.
2022 Jun 17;22(1):471. doi: 10.1186/s12909-022-03530-4. PubMed PMID:
35715779; PubMed Central PMCID:
PMC9205138.
Community-based naloxone coverage equity for the prevention of opioid overdose fatalities in racial/ethnic minority communities in Massachusetts and Rhode Island.
Addiction.
2022 May;117(5):1372-1381. doi: 10.1111/add.15759. Epub 2021 Dec 5. PubMed PMID:
34825427; PubMed Central PMCID:
PMC8983544.
Training in Adolescent Substance and Opioid Misuse in Pediatric Residency Programs.
Pediatrics.
2022 May 1;149(5). doi: 10.1542/peds.2021-053423. PubMed PMID:
35437591; PubMed Central PMCID:
PMC9107626.
"No home to take methadone to": Experiences with addiction services during the COVID-19 pandemic among survivors of opioid overdose in Boston.
J Subst Abuse Treat.
2022 Apr;135:108655. doi: 10.1016/j.jsat.2021.108655. Epub 2021 Nov 4. PubMed PMID:
34772604; PubMed Central PMCID:
PMC8576611.
Variation in Initiation, Engagement, and Retention on Medications for Opioid Use Disorder Based on Health Insurance Plan Design.
Med Care.
2022 Mar 1;60(3):256-263. doi: 10.1097/MLR.0000000000001689. PubMed PMID:
35026792; PubMed Central PMCID:
PMC8852217.
Abrupt Discontinuation From Long-Term Opioid Therapy in Massachusetts, 2015-2018.
Am J Prev Med.
2022 Mar;62(3):404-413. doi: 10.1016/j.amepre.2021.09.015. Epub 2021 Nov 24. PubMed PMID:
34838368.
Northeast Postacute Medical Facilities Disproportionately Reject Referrals For Patients With Opioid Use Disorder.
Health Aff (Millwood).
2022 Mar;41(3):434-444. doi: 10.1377/hlthaff.2021.01242. PubMed PMID:
35254930; NIHMSID:NIHMS1891284.
Limited access to pharmacy-based naloxone in West Virginia: Results from a statewide purchase trial.
Drug Alcohol Depend.
2022 Feb 1;231:109259. doi: 10.1016/j.drugalcdep.2021.109259. Epub 2021 Dec 31. PubMed PMID:
34998246; PubMed Central PMCID:
PMC8810724.
A collaborative care intervention to improve opioid prescribing among providers caring for persons with HIV: Impact on satisfaction, confidence, and trust.
Drug Alcohol Depend.
2022 Feb 1;231:109250. doi: 10.1016/j.drugalcdep.2021.109250. Epub 2021 Dec 29. PubMed PMID:
34998255.
Warrant checking practices by post-overdose outreach programs in Massachusetts: A mixed-methods study.
Int J Drug Policy.
2022 Feb;100:103483. doi: 10.1016/j.drugpo.2021.103483. Epub 2021 Oct 23. PubMed PMID:
34700251.
Translating Medicaid policy into practice: policy implementation strategies from three US states' experiences enhancing substance use disorder treatment.
Implement Sci.
2022 Jan 6;17(1):3. doi: 10.1186/s13012-021-01182-4. PubMed PMID:
34991638; PubMed Central PMCID:
PMC8734202.
Food insecurity and substance use in people with HIV infection and substance use disorder.
Subst Abus.
2022;43(1):104-112. doi: 10.1080/08897077.2020.1748164. Epub 2020 May 6. PubMed PMID:
32374225; PubMed Central PMCID:
PMC7644575.
Methadone initiation in a bridge clinic for opioid withdrawal and opioid treatment program linkage: a case report applying the 72-hour rule.
Addict Sci Clin Pract.
2021 Dec 28;16(1):73. doi: 10.1186/s13722-021-00279-x. PubMed PMID:
34961554; PubMed Central PMCID:
PMC8712102.
Targeting community-based naloxone distribution using opioid overdose death rates: A descriptive analysis of naloxone rescue kits and opioid overdose deaths in Massachusetts and Rhode Island.
Int J Drug Policy.
2021 Dec;98:103435. doi: 10.1016/j.drugpo.2021.103435. Epub 2021 Sep 3. PubMed PMID:
34482264; PubMed Central PMCID:
PMC8671216.
Outcomes of Ottawa, Canada's Managed Opioid Program (MOP) where supervised injectable hydromorphone was paired with assisted housing.
Int J Drug Policy.
2021 Dec;98:103400. doi: 10.1016/j.drugpo.2021.103400. Epub 2021 Aug 30. PubMed PMID:
34469781; PubMed Central PMCID:
PMC8881087.
"It could potentially be dangerous... but nothing else has seemed to help me.": Patient and clinician perspectives on benzodiazepine use in opioid agonist treatment.
J Subst Abuse Treat.
2021 Dec;131:108455. doi: 10.1016/j.jsat.2021.108455. Epub 2021 Apr 30. PubMed PMID:
34098286; PubMed Central PMCID:
PMC8556389.
Against Medical Advice Discharges in Injection and Non-injection Drug Use-associated Infective Endocarditis: A Nationwide Cohort Study.
Clin Infect Dis.
2021 Nov 2;73(9):e2484-e2492. doi: 10.1093/cid/ciaa1126. PubMed PMID:
32756935; PubMed Central PMCID:
PMC8563193.
Sexually Transmitted and Blood-borne Infections Among Patients Presenting to a Low-barrier Substance Use Disorder Medication Clinic.
J Addict Med.
2021 Nov-Dec 01;15(6):461-467. doi: 10.1097/ADM.0000000000000801. PubMed PMID:
34734572; PubMed Central PMCID:
PMC8569143.
Adaptation of a System of Treatment for Substance Use Disorders During the COVID-19 Pandemic.
J Addict Med.
2021 Nov-Dec 01;15(6):448-451. doi: 10.1097/ADM.0000000000000791. PubMed PMID:
33298750; PubMed Central PMCID:
PMC8562917.
A Resident-Led Intervention to Increase Initiation of Buprenorphine Maintenance for Hospitalized Patients With Opioid Use Disorder.
J Hosp Med.
2021 Jun;16(6):339-344. doi: 10.12788/jhm.3544. PubMed PMID:
34129484; PubMed Central PMCID:
PMC8191766.
Naloxone receipt and overdose prevention care among people with HIV on chronic opioid therapy.
AIDS.
2021 Mar 15;35(4):697-700. doi: 10.1097/QAD.0000000000002803. PubMed PMID:
33587441; PubMed Central PMCID:
PMC7904637.
Treating Withdrawal and Pain in Inpatients With Opioid Use Disorder: A Brief Educational Intervention for Internal Medicine Residents.
MedEdPORTAL.
2021 Mar 10;17:11123. doi: 10.15766/mep_2374-8265.11123. PubMed PMID:
33768154; PubMed Central PMCID:
PMC7970646.
Characteristics of post-overdose public health-public safety outreach in Massachusetts.
Drug Alcohol Depend.
2021 Feb 1;219:108499. doi: 10.1016/j.drugalcdep.2020.108499. Epub 2020 Dec 31. PubMed PMID:
33421800.
Rejection of Patients With Opioid Use Disorder Referred for Post-acute Medical Care Before and After an Anti-discrimination Settlement in Massachusetts.
J Addict Med.
2021 Jan-Feb 01;15(1):20-26. doi: 10.1097/ADM.0000000000000693. PubMed PMID:
32675798; PubMed Central PMCID:
PMC7859880.
"Health Is on the Back Burner:" Multilevel Barriers and Facilitators to Primary Care Among People Who Inject Drugs.
J Gen Intern Med.
2021 Jan;36(1):129-137. doi: 10.1007/s11606-020-06201-6. Epub 2020 Sep 11. PubMed PMID:
32918199; PubMed Central PMCID:
PMC7858998.
Changes in Infective Endocarditis Admissions in Pennsylvania During the Opioid Epidemic.
Clin Infect Dis.
2020 Oct 23;71(7):1664-1670. doi: 10.1093/cid/ciz1038. PubMed PMID:
31630192; PubMed Central PMCID:
PMC8241215.
The Clinical Microbiology Laboratory and the Opioid Epidemic: Challenges and Opportunities.
Infect Dis Clin North Am.
2020 Sep;34(3):465-478. doi: 10.1016/j.idc.2020.06.005. Review. PubMed PMID:
32782096; PubMed Central PMCID:
PMC7428057.
Inpatient addiction consultation and post-discharge 30-day acute care utilization.
Drug Alcohol Depend.
2020 Aug 1;213:108081. doi: 10.1016/j.drugalcdep.2020.108081. Epub 2020 May 25. PubMed PMID:
32485657; PubMed Central PMCID:
PMC7371521.
Comparison of Treatment Options for Refractory Opioid Use Disorder in the United States and Canada: a Narrative Review.
J Gen Intern Med.
2020 Aug;35(8):2418-2426. doi: 10.1007/s11606-020-05920-0. Epub 2020 May 27. Review. PubMed PMID:
32462569; PubMed Central PMCID:
PMC7403280.
Effect of Publicly Reported Aortic Valve Surgery Outcomes on Valve Surgery in Injection Drug- and Non-Injection Drug-Associated Endocarditis.
Clin Infect Dis.
2020 Jul 27;71(3):480-487. doi: 10.1093/cid/ciz834. PubMed PMID:
31598642; PubMed Central PMCID:
PMC7384313.
Improving Outcomes for People With Injection Drug-related Endocarditis: Are Medications for Opioid Use Disorder Enough?.
J Addict Med.
2020 Jul/Aug;14(4):280-0. doi: 10.1097/ADM.0000000000000573. PubMed PMID:
31634203; PubMed Central PMCID:
PMC7165029.
Internal Medicine Resident Perceptions of Patients with Substance Use Disorder After Attending a Mutual Support Group Meeting.
J Gen Intern Med.
2020 Mar;35(3):918-921. doi: 10.1007/s11606-019-05379-8. Epub 2019 Oct 30. PubMed PMID:
31667748; PubMed Central PMCID:
PMC7080948.
Hepatitis C Virus Antibody Testing Among 13- to 21-Year-Olds in a Large Sample of US Federally Qualified Health Centers.
JAMA.
2019 Dec 10;322(22):2245-2248. doi: 10.1001/jama.2019.16196. PubMed PMID:
31821424; PubMed Central PMCID:
PMC7081751.
Which patients receive an addiction consult? A preliminary analysis of the INREACH (INpatient REadmission post-Addiction Consult Help) study.
J Subst Abuse Treat.
2019 Nov;106:35-42. doi: 10.1016/j.jsat.2019.08.013. Epub 2019 Aug 20. PubMed PMID:
31540609; PubMed Central PMCID:
PMC6756179.
A scoping review of post opioid-overdose interventions.
Prev Med.
2019 Nov;128:105813. doi: 10.1016/j.ypmed.2019.105813. Epub 2019 Aug 19. PubMed PMID:
31437462.
Chronic Opioid Therapy in People Living With Human Immunodeficiency Virus: Patients' Perspectives on Risks, Monitoring, and Guidelines.
Clin Infect Dis.
2019 Jan 7;68(2):291-297. doi: 10.1093/cid/ciy452. PubMed PMID:
29860411; PubMed Central PMCID:
PMC6594413.
Trends in Drug Use-Associated Infective Endocarditis and Heart Valve Surgery, 2007 to 2017: A Study of Statewide Discharge Data.
Ann Intern Med.
2019 Jan 1;170(1):31-40. doi: 10.7326/M18-2124. Epub 2018 Dec 4. PubMed PMID:
30508432; PubMed Central PMCID:
PMC6548681.
Estimated Prevalence of Opioid Use Disorder in Massachusetts, 2011-2015: A Capture-Recapture Analysis.
Am J Public Health.
2018 Dec;108(12):1675-1681. doi: 10.2105/AJPH.2018.304673. Epub 2018 Oct 25. PubMed PMID:
30359112; PubMed Central PMCID:
PMC6236756.
Receipt of Timely Addiction Treatment and Association of Early Medication Treatment With Retention in Care Among Youths With Opioid Use Disorder.
JAMA Pediatr.
2018 Nov 1;172(11):1029-1037. doi: 10.1001/jamapediatrics.2018.2143. PubMed PMID:
30208470; PubMed Central PMCID:
PMC6218311.
Opioid and cocaine use among primary care patients on buprenorphine-Self-report and urine drug tests.
Drug Alcohol Depend.
2018 Nov 1;192:245-249. doi: 10.1016/j.drugalcdep.2018.08.010. Epub 2018 Sep 25. PubMed PMID:
30290291; PubMed Central PMCID:
PMC6291245.
Potentially Inappropriate Opioid Prescribing, Overdose, and Mortality in Massachusetts, 2011-2015.
J Gen Intern Med.
2018 Sep;33(9):1512-1519. doi: 10.1007/s11606-018-4532-5. Epub 2018 Jun 14. PubMed PMID:
29948815; PubMed Central PMCID:
PMC6109008.
Medication for Opioid Use Disorder After Nonfatal Opioid Overdose and Association With Mortality: A Cohort Study.
Ann Intern Med.
2018 Aug 7;169(3):137-145. doi: 10.7326/M17-3107. Epub 2018 Jun 19. PubMed PMID:
29913516; PubMed Central PMCID:
PMC6387681.
Tapering off and returning to buprenorphine maintenance in a primary care Office Based Addiction Treatment (OBAT) program.
Drug Alcohol Depend.
2018 Aug 1;189:166-171. doi: 10.1016/j.drugalcdep.2018.05.010. Epub 2018 Jun 19. PubMed PMID:
29958128; PubMed Central PMCID:
PMC6139651.
What would you like to do?